Science Explorer Back to mapMap
Discussion
Researcher · Epic Sciences (United States) · United States

Mark Andrew Landers

Mark Andrew Landers publishes mostly in Oncology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Cancer Cells and Metastasis and Prostate Cancer Treatment and Research.

OpenAlex
World rank
#1,039,058
of 7,710,434 ranked researchers
Rank in United States
#337,986
of 1,627,098
Works
104
Citations
2.1k
Citations per work
19.9
h-index
16
i10-index 19Top 33% in Oncology
Mark Andrew Landers

What does Mark Andrew Landers research?

Mark Andrew Landers's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (34%).

Health Sciences: 56 works · 54.2% of their workMedicine: 56 works · 54.2% of their workOncology: 27 works · 26.3% of their workPulmonary and Respiratory Medicine: 18 works · 17.5% of their workRadiology, Nuclear Medicine and Imaging: 11 works · 10.4% of their workLife Sciences: 35 works · 33.8% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 33.8% of their workCancer Research: 23 works · 21.7% of their workMolecular Biology: 11 works · 10.8% of their workGenetics: 1 works · 1.3% of their workEverything else: 12 works · 12.0% of their workTHEIR WORKMark AndrewLanders104works
Life Sciences34%Health Sciences54%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5654.2%
    1. Biochemistry, Genetics and Molecular Biology3533.8%
  3. Everything else1212.0%
  1. 1Oncology26% of their works
  2. 2Cancer Research22% of their works
  3. 3Pulmonary and Respiratory Medicine18% of their works
  4. 4Molecular Biology11% of their works
  5. 5Radiology, Nuclear Medicine and Imaging10% of their works
  6. 6Genetics1% of their works

Research topics

Which keywords describe Mark Andrew Landers's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Cancer Stem Cells, Tumor Metastasis, Androgen Receptor, Prostate Cancer and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Targeted Therapy542 topics
  2. Cancer Genomics441 topic
  3. Mutational Signatures441 topic
  4. Cancer Stem Cells351 topic
  5. Tumor Metastasis351 topic
  6. Androgen Receptor291 topic
  7. Prostate Cancer291 topic
  8. Immune Checkpoint Blockade141 topic
  9. PD-1 and PD-L1141 topic
  10. PET Imaging101 topic
  11. Radiopharmaceuticals101 topic
  12. BRCA Mutation81 topic
  13. PARP Inhibitors81 topic
  14. Imaging71 topic
  15. PET/CT71 topic
  16. Medical Imaging61 topic
  17. Radiomics61 topic

Where does Mark Andrew Landers work?

Mark Andrew Landers's main affiliation in the publication record is Epic Sciences (United States), United States.

How many publications and citations does Mark Andrew Landers have?

OpenAlex counts 104 works and 2,067 citations for Mark Andrew Landers, an h-index of 16, ranking #1,039,058 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark Andrew Landers. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.